Quadrant Capital Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-112	Closed	-$16K	–	2917
2022 Q2	$16K	Buy	112 +31	+38%	+$4.43K	﹤0.01%	1427
2022 Q1	$10K	Buy	+81	New	+$10K	﹤0.01%	1671
2021 Q4	–	Sell	-13	Closed	-$2K	–	2813
2021 Q3	$2K	Buy	+13	New	+$2K	﹤0.01%	2230